Nurse Practitioner, Family · New Orleans, LA
NPI
1639501307
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1514 Jefferson Hwy, Department of Endocrinology
New Orleans, LA, 70121
Phone (504) 842-4023
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
595 services
Medicare patients, 2024
157
Average age 71
Drug cost, 2024
$3.2M
5,593 prescriptions
Company payments, 2025
$329
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ainsley N Jarrott was code 99214 (office e&m - established), 307 times for 147 patients. In total Ainsley N Jarrott billed 595 services in 7 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 147 | $56.62 | $17K |
| 95251 Test - Miscellaneous | Office | 162 | 76 | $20.37 | $3,301 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 95 | 64 | $10.49 | $997 |
| 99204 Office E&M - New | Office | 14 | 14 | $84.69 | $1,186 |
By year: 2022 $23K for 479 services; 2023 $24K for 500 services; 2024 $24K for 595 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ainsley N Jarrott prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 754 prescriptions and refills. In total Ainsley N Jarrott wrote 5,593 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 754 | 948 | 136 | $1.0M |
| Jardiance Empagliflozin | 510 | 739 | 106 | $426K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 352 | 647 | 79 | $196K |
| Ozempic Semaglutide | 331 | 421 | 82 | $389K |
| Metformin Hcl Er Metformin Hcl | 285 | 737 | 92 | $2,221 |
| Novolog Flexpen Insulin Aspart | 261 | 466 | 92 | $68K |
| Metformin Hcl Generic | 244 | 623 | 73 | $1,911 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 200 | 393 | 64 | $23K |
| Glimepiride Generic | 198 | 515 | 54 | $1,732 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 158 | 312 | 68 | $17K |
| Humalog Kwikpen U-100 Insulin Lispro | 124 | 184 | 36 | $39K |
| Januvia Sitagliptin Phosphate | 124 | 201 | 27 | $111K |
| Levothyroxine Sodium Generic | 121 | 249 | 32 | $886 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 119 | 231 | 31 | $143K |
| Trulicity Dulaglutide | 114 | 159 | 31 | $154K |
Brand drugs: 3,735 claims; generic drugs: 1,393 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ainsley N Jarrott $329 ($329 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sequel Med Tech, LLC with $152.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.